Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia

Rheumatology International

Volumn 27, Issue 8, 2007, Pages 763-765

  Ozdogu, Hakan ^a   Boga, Can ^a   Yılmaz, Zerrin ^a   Sahin, Feride Iffet ^a   Bal, Nebil ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Colchicine; Malignant transformation; Promyelocytic leukemia; Retinoic acid

Indexed keywords

COLCHICINE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; RETINOIC ACID;

ADULT; ANAMNESIS; ARTICLE; BEHCET DISEASE; BLOOD SMEAR; BONE MARROW CULTURE; CASE REPORT; CHROMOSOME ANALYSIS; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; MALE; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 34248143536     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0285-2     Document Type: Article

References (14)

1. Arayssi T, Hamdan A (2004) New insights into the pathogenesis and therapy of Behcet's disease. Curr Opin Pharmacol 4:183-188
2. Louzir B, Othmani S, Gritli N, Beji M, Zid B, M'Saddek F, Boussema E, Bahri M (1992) Erythroleukemia in a patient with Behcet's disease under long-term thalidomide therapy. Ann Med Interne (Paris) 143:479-480
3. Kaloterakis A, Stavrianeas NG, Karagianni IN, Filiotou A, Katoulis AC, Vareltzides A, Hadjiyannis S (1997) Adamantiades-Behcet's disease coexisting with acute myeloblastic leukaemia. Br J Dermatol 137:317-318
4. Oo TH, Delafuente M, Hassoun H (2003) Possible association between hairy cell leukemia and Behcet's disease. South Med J 96:323-324
5. Verma RS, Babu A (1995) Human chromosomes. Tissue culture techniques and chromosome preparation, 2nd edn. McGraw-Hill, New York
6. Hoang T, Levy B, Onetto N, Human A, Rodriguez-Cimadevilla JC (1989) Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. J Exp Med 170:15-26
7. Abbas KA, Lichtman HA (2003) Cellular and molecular immunology, 5th edn. Elsevier, Philadelphia
8. Allen JN, Herzyk DJ, Wewers MD (1991) Colchicine has opposite effects on interleukin-1 beta and tumor necrosis factor-alpha production. Am J Physiol 261:315-321
9. Fontes V, Machet L, Huttenberger B, Huttenberg B, Lorette G, Vaillant L (2002) Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases. Ann Dermatol Venereol 129:1365-1369
10. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F, Pelicci PG (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83:10-25
11. Vallarino-Kelly T, Morales-Ramirez P (2001) Kinetics of micronucleus induction and cytotoxic activity of colchicine in murine erythroblast in vivo. Mutat Res 495:51-59
12. Ferrannini E, Pentimone F (1984) Marrow aplasia following colchicine treatment for gouty arthritis. Clin Exp Rheumatol 2:173-175
13. Honma M, Momose M, Sakamoto H, Sofuni T, Hayashi M (2001) Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat Res 493:101-114
14. Leung MF, Sartorelli AC (1992) The effects of microtubule disrupting drugs on the differentiation of HL-60 leukemia cells. Leuk Res 16:929-935